Hence, targeted inhibition of p38α MAPK could be therapeutically beneficial to PDT, since it would prevent COX-2 expression, the inducible release of growth and angiogenic factors by the cancer cells, and cause an increase in the levels of free arachidonic acid which promotes apoptosis. The gene discussed is PTGS2; the disease is cancer.